Dengue NS1 antigen as a marker of severe clinical disease.

摘要: Early detection of complications significantly reduces dengue associated mortality and morbidity. We set out to determine if the NS1 rapid antigen test could be used as a point care predict severe disease. 186 adult patients with confirmed were enrolled during day 3-8 illness. Clinical laboratory parameters recorded course illness levels determined using both Panbio early ELISA (Panbio, Australia) kit (SD Bioline, South Korea). 59.1% presented hospital on 5-6 when positivity was (p = 0.008) (odds ratio 3.0, 95% CI 1.39 6.47) higher 0.03) in those who went develop shock. Serum < 0.0001) inversely correlated total white cell counts lymphocyte counts. The bedside showed comparable sensitivity (97.4%) specificity (93.7%) our setting cohort. is risk developing especially positive beyond 5 cohort, while further validation studies are required, can therefore potentially warning sign dengue.